Hongene has appointed leading lipid nanoparticle (LNP) researcher Pieter Cullis [...]

A newly published benchmark dataset is helping push variant detection [...]

As debate continues over the cost and sustainability of GLP-1 [...]

Axplora has announced a €6.5 million investment at its Vizag [...]

Ethris has dosed the first patient in a Phase 2a [...]

Nucleus Network has acquired UK-based Hammersmith Medicines Research (HMR), a [...]

New data presented at the Alzheimer’s Association International Conference 2025 [...]

A new investigational HIV vaccine candidate, GRAdHIVNE1, has entered Phase [...]

New natural language capability aims to reduce barriers for researchers [...]

No-code platform opens early access to generative binder design with [...]